Evommune, Inc. (EVMN)
12.46
-0.20
(-1.58%)
USD |
NYSE |
Sep 01, 14:29
Evommune Cash from Operations (TTM) : -74.15M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -74.15M |
| March 31, 2026 | -80.04M |
| December 31, 2025 | -76.44M |
| Date | Value |
|---|---|
| September 30, 2025 | -85.97M |
| June 30, 2025 | -84.96M |
| March 31, 2025 | -63.58M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| MapLight Therapeutics, Inc. | -174.67M |
| Mineralys Therapeutics, Inc. | -138.79M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |